LOVELAND, CO - January 27, 2026 - PRESSADVANTAGE - As awareness grows around early detection and management of ...
CEDAR RAPIDS, IA - January 27, 2026 - PRESSADVANTAGE - As cases of glaucoma continue to rise across the United States, ...
Please provide your email address to receive an email when new articles are posted on . The Omni procedure helped reduce IOP across all severities of glaucoma. The procedure produced a low secondary ...
Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.
The January 31, 2026, conference in Mainz, Germany, will focus on advances in optic neuropathy diagnosis, artificial ...
Medical Device Network on MSN
Myra Vision enrols first patient in trial of Calibreye glaucoma system
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
Morning Overview on MSN
New study flags powerful drug target that could transform glaucoma treatment
Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting ...
Glaucoma is scary for one simple reason, it doesn’t warn you before it starts taking your vision away. Most eye problems give ...
MENLO PARK, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Sight Sciences (SGHT), Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and ...
Fitbit-recorded physical activity showed no definitive relationship with the diagnosis of primary open-angle glaucoma in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results